. This family consists of five members, RelA, RelB, c-Rel, NF-κ B1 (p50 and its precursor p105), and NF-κ B2 (p52 and its precursor p100), and promotes transcription as hetero-or homo-dimers 3 . NF-κ B is sequestered in the cytosol by binding to inhibitory proteins in unstimulated cells, and then translocate to the nucleus upon receiving various ligand signals. Translocation of NF-κ B is mediated by
Scientific RepoRts | 5:10758 | DOi: 10.1038/srep10758 two distinct intracellular signaling pathways, canonical and non-canonical NF-κ B pathways 4 . The canonical NF-κ B pathway requires the Iκ B kinase (IKK) complex including IKKα , IKKβ , and IKKγ and results in nuclear translocation of NF-κ B dimers typically consisting of RelA and p50, which in turn up-regulate genes required for innate immune responses and cell survival. In contrast to the canonical NF-κ B pathway, the non-canonical NF-κ B pathway does not require IKKβ and IKKγ , while IKKα is essential for mediation of the signaling pathway. IKKα phosphorylates inhibitory protein p100 that preferentially binds to RelB. Phosphorylation of p100 is followed by partial degradation of p100 to p52. Consequently, the p52 and RelB heterodimer complex is translocated into the nucleus for transcriptional activation 5 . NF-κ B-inducing kinase (NIK) was originally identified as a serine/threonine kinase that activates the canonical NF-κ B pathway 6 . However, later studies revealed an essential role of NIK in non-canonical NF-κ B activation. NIK-deficient mice and alymphoplasia (aly) mice, which have a dysfunctional point mutation in the Nik gene, lack lymph nodes, Payer's patches, and organized structures of the spleen and thymus [7] [8] [9] . These phenotypes are similar to those of RelB-deficient mice 10 . Moreover, ligand-dependent phosphorylation of IKKα and processing of p100 are abolished by the absence of functional NIK in mouse embryonic fibroblasts (MEFs) 11 . These data suggest that NIK is a critical activator of the non-canonical NF-κ B pathway to activate RelB via phosphorylation of IKKα and subsequent partial degradation of p100. In addition to its physiological significance, deregulation of NIK activation is reportedly associated with the onset of multiple myeloma and inflammatory diseases [12] [13] [14] . Under these pathological conditions, canonical and non-canonical NF-κ B pathways are constitutively activated by NIK. These findings suggest a biological significance of the precise regulation of NIK-dependent NF-κ B activation.
Activation of NIK is controlled by its phosphorylation and proteasome-dependent degradation 15 . In unstimulated cells, NIK is recruited to a complex consisting of TNF receptor-associated factor (TRAF) 3, TRAF2, and cellular inhibitor of apoptosis 1 or 2 (cIAP1/2) ubiquitin ligase through binding to TRAF3. The TRAF3-TRAF2-cIAP1/2 complex induces polyubiquitination and subsequent proteasomal degradation of NIK in unstimulated cells 16 . As a result, the constitutive degradation limits the amount of NIK protein at biochemically undetectable level in unstimulated cells. Ligand stimulation of receptors triggers self-degradation of the TRAF3-TRAF2-cIAP1/2 complex, thereby leading to stabilization and accumulation of NIK. Accumulated NIK induces autophosphorylation of Thr-559, which is required for phosphorylation of downstream IKKα for signal transduction 17 . In addition, a recent study has revealed novel feedback inhibition of NIK activity by IKKα -mediated phosphorylation of NIK at Ser-809, Ser-812, and Ser-815, leading to destabilization of NIK protein 18 . Calcineurin is a serine/threonine protein phosphatase including a catalytic subunit (CnA) and regulatory subunit (CnB), which participates in calcium ion-dependent signal transduction pathways 19 . Calcineurin activates nuclear factor of activated-T cells (NFAT) by dephosphorylation. Previous studies have elucidated the roles of calcineurin in NF-κ B activation. Calcineurin enhances T-cell antigen receptor (TCR)-mediated NF-κ B activation by regulating formation of the Carma1-Bcl10-Malt1 complex 20, 21 . In contrast, inhibition of calcineurin in murine macrophages enhances the nuclear localization of RelA induced by Toll-like receptor (TLR) signaling. Thus, calcineurin is a positive regulator of TCR signaling and a negative regulator of TLR signaling. These findings suggest the involvement of calcineurin in the canonical NF-κ B pathway. However, the role of calcineurin remains to be determined in the non-canonical NF-κ B pathway.
In this study, we identified calcineurin catalytic subunit Aα and Aβ isoforms (CnAα and CnAβ , respectively) as novel NIK-interacting proteins. Small interfering (si)RNA-mediated depletion of CnAα and CnAβ (CnAα /β ) enhanced nuclear translocation of RelA and RelB and expression of a NIK-dependent target gene, Spi-B. Thus, our data suggest that CnAα /β are negative regulators of NIK-mediated signaling.
Results
NIK binds to the catalytic subunits of calcineurin. To identify novel NIK-binding proteins, we performed in vitro selection of NIK-binding proteins using the combination of cell-free co-translation and an "in vitro virus" (IVV) technology [22] [23] [24] . This selection consisted of several steps: in vitro transcription and cell-free co-translation of bait NIK and prey cDNAs, IVV selection, and amplification of the selected IVVs by RT-PCR (see Methods for detail). Relatively weak interaction between NIK and NIK-binding peptides was detected by multiple rounds of this procedure. We screened a cDNA expression library from mouse embryonic thymus and obtained 29 candidates as novel NIK-binding proteins (Table 1) . Because the function of NIK is positively or negatively controlled by phosphorylation and proteasome-dependent degradation 15 , respectively, we focused on possible regulators of these biochemical reactions (e.g., kinases, phosphatases, and ubiquitin ligases). Among the 29 candidates, we further validated CnAα as a possible regulator of NIK by co-immunoprecipitation studies (validation of some other candidates are shown in Table 1 ). To verify the interaction between CnAα and NIK in living cells, Flag-tagged NIK and Myc-tagged CnAα were transiently co-expressed in human embryonic kidney (HEK) 293T cells. A co-immunoprecipitation assay revealed that CnAα bound to NIK in HEK293T cells (Fig. 1A) .
The CnA family consists of three isoforms encoded by different genes: CnAα , CnAβ , and the calcineurin catalytic subunit Aγ isoform (CnAγ ). CnAα /β are expressed ubiquitously and usually function in a redundant manner, whereas expression of CnAγ is testis specific 25 . Despite the similarity in structure, the NIK-CnAβ interaction was not detected in the first screening, which could occur possibly due to technical reasons (e.g. possible biased amplifications during multiple rounds selections and PCR). Therefore, we tested binding of CnAβ to NIK in a co-immunoprecipitation assay. Indeed, co-immunoprecipitation indicated that CnAβ also interacted with NIK in HEK293T cells (Fig. 1A) . These data suggested a common binding activity of CnAα /β for NIK. To gain some insight into the function of CnAα /β in NIK-dependent signaling, we next determined the responsible domains in NIK for its binding to CnAα /β . NIK has a serine/threonine kinase domain that is essential for activation of NIK itself and downstream signal-transducing molecules 15 . The serine/threonine kinase region intervenes between the N-terminal and C-terminal regions (Fig. 1A) . The N-terminal region contains the binding site for TRAF3 that is critical for degradation of NIK. The C-terminal region includes the binding site for IKKα that is phosphorylated by NIK and subsequently mediates downstream activation of the NF-κ B pathway. To determine the CnAα /β -binding region in NIK, we analyzed various deletion mutants of NIK co-expressed with CnAα in HEK293T cells ( Fig. 1A ; left). A co-immunoprecipitation assay showed that deletion of both the C-terminal region and kinase domain (Δ KC mutant in Fig. 1B ) abolished binding to CnAα , whereas the deletion mutant lacking only the C-terminal region still bound to CnAα (Δ C mutant in Fig. 1B ). This finding suggests that the kinase domain binds to CnAα . Furthermore, the mutant lacking both the N-terminal region and kinase domain bound to CnAα (Δ NK in Fig. 1B ), indicating that the C-terminal region also binds to CnAα . Thus, either the C-terminal region or the kinase domain (Δ NK and Δ NC in Fig. 1B , respectively) is sufficient for interacting with CnAα ( Fig. 1A ; right). As expected because of their similarity, binding regions of CnAβ in NIK were similar to those of CnAα (Fig. 1A ) although the interaction of NIK with Δ C mutant of CnAβ is relatively weaker than that of CnAα . These data suggest that NIK recruits CnAα /β via two distinct regions, the kinase domain and C-terminal region. We next examined the NIK-binding region in CnAα . CnAα consists of several domains: an N-terminal phosphatase catalytic domain, regulatory subunit binding domain, calmodulin-binding domain, and autoinhibitory domain ( Fig. 2A ) 24 . C-or N-terminal deletion mutants of CnAα (CnAα Δ C and CnAα Δ N in Fig. 2A ) were co-expressed with NIK in HEK293T cells. A co-immunoprecipitation assay showed that NIK bound to the C-terminal deletion mutant (CnAα Δ C), but not the N-terminal deletion mutant (CnAα Δ N) (Fig. 2B) . Thus, CnAα binds to NIK via its phosphatase domain.
These data suggest that the phosphatase domain of CnAα /β interacts with the kinase domain and C-terminal domain of NIK. Because NIK is recruited to a protein complex consisting of TRAF2, TRAF3, and cIAPs in unstimulated cells, we next determined whether CnAα /β also interact with this protein complex.
CnAα/β bind to TRAF3. The protein complex consisting of TRAF2, TRAF3, and cIAP1 or cIAP2 mediates polyubiquitination of NIK, thereby initiating its degradation in unstimulated cells 5 . TRAF3 in this protein complex binds to NIK. Interestingly, a co-immunoprecipitation assay indicated that CnAα /β bound to TRAF3 in transfected HEK293T cells (Fig. 3) . Thus, in addition to NIK, CnAα /β bind to TRAF3. These results support the idea that CnAα /β binds to a transient protein complex containing TRAF3 and NIK, which should be formed before proteasome-dependent constitutive degradation of NIK in unstimulated cells. Interestingly, affinity of CnAβ with TRAF3 seemed to be higher than that of CnAα , which implying the difference between these two homologues in contribution to function of NIK-TRAF3 complex. Because CnAα /β interact with NIK and its regulator TRAF3, we next addressed the roles of CnAα /β in NIK-mediated gene expression induced by receptor ligations.
Transcription factor Spi-B is a target gene of NIK-mediated signaling triggered by ligation of lymphotoxin β-receptor. TNF receptor family lymphotoxin β receptor (LTβ R) signaling has been reported to activate NIK-mediated non-canonical NF-κ B activation and thereby inducing the expression of numerous chemokines including Cxcl13, Ccl19, and Ccl21 in peripheral lymphoid tissues [26] [27] [28] . However, we failed to detect significant up-regulation of these genes in MEFs, which is consistent with previous observations 29, 30 . Therefore, we first searched for a target gene induced by LTβ R-NIK signaling in MEFs.
We have recently found that NIK activation induces expression of a splice variant of Spi-B (hereafter referred to as Spi-B1) in TNF receptor family member RANK signaling 31 . That study suggested that Spi-B1 is a direct target gene of NIK-mediated activation of NF-κ B signaling because overexpression of NIK and the RelB complex activates the proximal promoter of the Spi-B1 gene 31 . Because LTβ R signaling activates NIK-dependent NF-κ B pathways similarly to RANK signaling 32 , we first tested whether Ltβ R signaling induces Spi-B1. MEF cells were stimulated with an agonistic anti-Ltβ R antibody. Quantitative PCR (qPCR) analysis indicated that Ltβ R signaling efficiently up-regulated Spi-B1 (Fig. 4A,B) .
We next confirmed that Ltβ R signaling-mediated expression of Spi-B1 is dependent on NIK activity. The Aly/aly mice line has a point mutation in the coding region of the Nik gene 8 . Because the aly/aly mutation abrogates binding of NIK to IKKα 33 , there is a severe impairment in NF-κ B activation mediated by NIK-IKKα . We isolated MEFs from aly/aly mice and determined whether Ltβ R signaling-mediated Spi-B1 expression is dependent on the NIK-IKKα axis by qPCR analysis. In fact, up-regulation of Spi-B1 induced by Ltβ R stimulation was abolished in aly/aly MEFs (Fig. 4A) . Thus, the NIK-IKKα interaction is essential for Ltβ R signaling-dependent expression of Spi-B1 in MEFs.
Because the Ltβ R-NIK-IKKα signaling axis was confirmed to induce Spi-B1 expression in MEFs, we next addressed the function of CnAα /β in the Ltβ R signaling-dependent Spi-B1 expression in MEFs.
CnAα/β attenuates expression of Spi-B and nuclear translocation of RelA and RelB induced by NIK-mediated signaling. Protein expression of CnAα /β was suppressed by siRNA-mediated knockdown in MEFs (Fig. 4B) . We found that siRNA-mediated knockdown of CnAα /β resulted in a significant increase in the expression Spi-B induced by LTβ R ligation (Fig. 4B, right) . Effect of the CnAβ depletion were prominent as compared to that of the CnAα depletion, which is consistent with the observation that the affinity of CnAβ with TRAF3 was higher than that of CnAα (Fig. 3) . Double knockdown of CnAα /β led to remarkable up-regulation of Ltβ R-mediated Spi-B expression, suggesting partial redundancy of these two isoforms. The enhancement of Spi-B expression by CnAα /β knockdown was not observed in aly/aly MEFs (Fig. 4A ). This result is consistent with the idea that CnAα /β -dependent regulation of Spi-B expression is mediated by NIK. The basal level of Spi-B expression (without anti-Ltβ R antibody stimulation) seemed to be elevated by CnAα /β deletion (Fig. 4A,B) .
NIK-mediated activation of canonical and non-canonical NF-κ B pathways leads to activation of RelA and RelB complexes, respectively, thereby enhancing gene expression 15 . Because CnAα /β negatively regulated NIK-mediated Spi-B expression, we next determined the role of CnAα /β in NF-κ B activation induced by Ltβ R-NIK signaling. Because nuclear translocation is a critical hallmark of NF-κ B activation, we examined whether CnAα /β negatively regulate Ltβ R signaling-mediated nuclear translocation of RelA and RelB. As reported previously 34 , nuclear RelA and RelB levels were increased by stimulation with the agonistic anti-Ltβ R antibody in MEFs. Depletion of both CnAα /β increased the amount of nuclear RelA and RelB induced by Ltβ R signaling (Fig. 4C) , whereas the total amount of RelA and RelB was not significantly influenced by Ltβ R stimulation (Fig. 5A) . These data suggest that CnAα /β cooperatively attenuate NIK-mediated NF-κ B activation, thereby negatively regulating expression of the NIK-dependent gene Spi-B. Therefore, we next determined whether CnAα /β is involved in the NIK-mediated signaling pathway of non-canonical NF-κ B activation.
CnAα/β negatively regulate processing of p100 to p52 induced by LtβR and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) signaling. It is known that Ltβ R-NIK signaling induces processing of p100 to p52 5 . Indeed, stimulation with the agonistic anti-Ltβ R antibody led to a reduction of p100 and an incremental increase of p52 in MEFs (Fig. 5A) . CnAβ depletion slightly increased the amount of p52 induced by stimulation with the anti-Ltβ R antibody (Fig. 5A) . However, there were marginal effects of CnAα /β depletion. Therefore, we used recombinant TWEAK protein as a ligand to confirm the effect of CnAα /β depletion on p100 processing. Binding of TWEAK to its receptor, Fn14, effectively induced processing of p100 to p52 in MEFs (Fig. 5B) , which is consistent with previous studies 35, 36 . Depletion of CnAα or CnAβ caused an increase in the amount of processed p52. Interestingly, the level of total NF-κ B2 protein (i.e., both p52 and p100) in cells was also increased in CnAα /β knockdown MEFs stimulated with TWEAK (Fig. 5B) . Thus, CnAα /β inhibit the expression and processing of p100 induced by the TWEAK-Fn14 axis. Because canonical NF-κ B activation reportedly up-regulates p100 expression 34 , these data are consistent with the idea that CnAα /β attenuates both canonical and non-canonical NF-κ B activation. Our data suggest that CnAα /β negatively regulates processing of p100 to p52 induced by ligand signaling.
Discussion
Calcium ions play a critical role in a variety of signal transduction pathways as a second messenger 37 . Calcineurin mediates certain calcium signaling pathways by dephosphorylation of NFAT 24 . Several studies have reported that intracellular calcium ions modulate NF-κ B activity. Calcineurin enhances activation of the canonical NF-κ B pathway in T cells by promotion of Carma1-Bcl10-Malt1 complex formation 20, 21 , while it attenuates TLR-dependent activation of the canonical NF-κ B pathway by inhibition of the essential adaptor MyD88 and TRIF 38 . Here, we propose that CnAα /β negatively regulate the non-canonical NF-κ B pathway mediated by NIK. Thus, our data suggest the possibility of novel cross-talk between calcium signaling and the non-canonical NF-κ B pathway induced by TNF family signaling.
An important aspect is the mechanism by which CnAα /β control NIK activity. Deletion mutant experiments suggest that CnAα /β interact with NIK via the phosphatase domain. Because NIK mediates downstream signaling by autophosphorylation and phosphorylation of downstream target molecules, it is possible that NIK-interacting CnAα /β dephosphorylates substrates of NIK, thereby inhibiting the function of NIK as a signal transducer. Further in-depth structural and biochemical studies are necessary to determine the molecular mechanism of CnAα /β -mediated regulation of NIK activity.
Single knockdown of CnAα or CnAβ enhanced processing of p100 to p52 induced by TWEAK signaling, whereas an additive effect was not observed by double knockdown of CnAα /β (Fig. 5) . Assuming that the role of CnAα /β in regulation of NIK functions is redundant, NIK-dependent p100 processing may be already maximized by elimination of either CnAα or CnAβ . Conversely, nuclear localization of RelA and RelB was not clearly enhanced by single knockdown of CnAα or CnAβ , but it was increased by double knockdown of CnAα /β . Moreover, expression of the target Spi-B gene was more efficiently up-regulated in double knockdown cells compared with that in single knockdown cells. One possible explanation for these observations is that CnAs negatively regulate the NIK-mediated NF-κ B activation pathway via two independent mechanisms. Thus, one mechanism influences processing of p100 to p52 and may be relatively sensitive to reductions in the amounts of CnAs in cells, while another mechanism affects nuclear localization of the NF-κ B complex and may be less sensitive to CnA depletion. This idea may be consistent with the fact that CnAs bind to NIK at two distinct regions (Fig. 1) . Thus, CnAs may inhibit the function of NIK via two mechanisms through interacting with the kinase domain or C-terminal region in NIK.
Deregulation of NF-κ B induces tumorigenesis and inflammatory diseases 15, 39 . Therefore, NF-κ B activity needs to be finely tuned and ceased appropriately at the end of stimulation. Previous studies have indicated that deregulation of NIK leads to activation of canonical and non-canonical NF-κ B pathways, which is associated with the pathogenesis of multiple myeloma 12, 13 . Our data imply that CnAα /β may be novel modulators of NIK activity. Although it is unknown whether CnAα /β -mediated inhibition of NIK activity is also active in other cell types such as B cells or plasma cells, it would be interesting to investigate whether abolition or attenuation of calcineurin-mediated NIK inhibition can initiate or promote malignant B-cell tumors or other types of tumors.
Because proper regulation of NIK activation is essential to prevent the onset of cancer and inflammatory diseases, further studies on calcineurin-mediated inhibition of NIK activity might provide important insights into the development of anti-tumor or anti-inflammatory drugs in the future. In vitro virus selection. First, randomly primed reverse transcription of fetal thymus poly(A)+ mRNAs were subjected to ligation mediated amplification and multi-step PCRs to create cDNA constructs for in vitro expression. The resulting PCR products (SP6-Ω -T7-Flagment-Kpn1-FLAG) were purified with a QIAquick PCR Purification Kit (Qiagen, Germany) and transcribed into mRNA with a RiboMAX Large Scale RNA Production System-SP6 (Promega, WI, USA) and an m7G(5')ppp(5')G RNA Cap Structure Analog (Ambion, Life Technologies, CA, USA). After purification of the transcribed mRNAs using an RNeasy 96 BioRobot 8000 Kit (Qiagen), PEG Puro spacer was ligated to the 3' ends of mRNAs using T4 RNA ligase (Promega) and the RNA was purified again. A cDNA for the bait (NIK) was prepared similarly. In vitro virus selection was performed as previously reported. Briefly, mRNA templates used as bait and prey were co-translated in a wheat germ extract (Zoegene Corporation, now Molecuence Corporation) for 1 h at 26 °C in 96-well plates by using Qiagen Biorobot 8000. At the same time, the in vitro virus molecules were formed by covalently attaching the 3' end of mRNA for prey to the C-terminus of its coding protein via puromycin. After each round of selection, prey mRNA was amplified by RT-PCR, followed by the in vitro transcription and translation reactions that prepared the library for the next round of selection. After four rounds of selection, interaction sequence tags obtained by in vitro virus selection were identified by Takara Bio Inc., Otsu, Japan and Shimadzu Corporation, Genomic Research Center, Kyoto, Japan. A mock experiment was performed without bait protein as the negative control to eliminate technical false positive results.
Methods
Cell culture, transfection, and siRNA-mediated knockdown. Aly/+ and aly/aly MEFs were prepared from whole embryos of aly/+ and aly/aly mice (CLEA, Japan). Briefly, embryos were dispersed in PBS containing 0.25% trypsin and 1 mM EDTA. After removal of the enzyme solution, the dispersed cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, glutamate, penicillin (100 U/ml), and streptomycin (100 U/ml). Attached cells were subjected to assays. HEK293T cells and MEFs were maintained in DMEM supplemented with 10% fetal bovine serum, glutamate, penicillin (100 U/ml), and streptomycin (100 U/ml). Transfection of HEK293T cells was performed using the calcium phosphate method. siRNAs were transfected using RNAiMAX reagents (Life Technologies, Rockville, MD). As a control siRNA, we used a medium GC % negative control Stealth siRNA (Invitrogen, Carlsbad, CA). The following double strand siRNAs (Life Technologies) were used to silence CnAα and CnAβ : CnAα , sense 5´-UAA ACG UGA AAU ACU CUG UGA GGU G-3′ and antisense 5′ -CAC CUC ACA GAG UAU UUC ACG UUU A-3′ ; CnAβ , sense 5′ -GCU GUG CAG CAA GAU GGU UUC AAU U-3′ and antisense 5′ -AAU UGA AAC CAU CUU GCU GCA CAG C-3′ .
Plasmids. Expression vectors encoding full-length and truncated forms of NIK and CnAα were generated by PCR amplification of NIK and CnAα cDNAs (provided by RIKEN), followed by subcloning the amplified DNA fragments into vectors.
Antibodies and reagents.
We used the following antibodies: anti-Flag M2 (F3165) (Sigma-Aldrich, St Louis, MO), mouse anti-Myc (sc-40), rabbit anti-Myc (sc-789), mouse anti-HA (sc-805), anti-Parp1 (sc-25780), mouse anti-TRAF3 (sc-6933), rabbit anti-TRAF3 (sc-1828), anti-p65 (sc-8008) (Santa Cruz Biotechnology, Santa Cruz, CA), anti-NIK (4994), anti-p52 (4882), anti-RelB (4922s) (Cell Signaling, Beverly, MA), anti-CnAα (07-067), anti-CnAβ (07-068), anti-tubulin (CP06) (Millipore, Darmstadt, Germany). The following reagents used were in experiments: MG132 (Peptide Institute, Osaka, Japan) and an agonistic anti-Ltβ R antibody (Alexis Biochemicals, Läufelfingen, Switzerland).
In vitro virus selection was performed as reported previously 22 . Briefly, a cDNA library was prepared from mouse fetal thymus RNA (embryonic day 18.5). NIK mRNA was used as bait, and prey were co-translated in a wheat germ extract (Molecuence, Yokohama, Japan) using a Qiagen Biorobot 8000. After four rounds of selection, we identified interaction sequence tags obtained by in vitro virus and verified them as reported previously 23, 40 .
Immunoprecipitation and immunoblotting.
Lysates of HEK293T cells and MEFs were prepared in TNE buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 1 mM sodium orthovanadate, and a protease inhibitor mixture). The lysates were precleared in a protein G-sepharose column (GE Healthcare, Chalfont St Giles, UK) and immunoprecipitated with the indicated antibodies, followed by incubation with protein G-sepharose. For endogenous immunoprecipitation of TRAF3, MEFs were pretreated with 10 mM MG132 for 2 h before harvesting. For immunoblot analysis, immunoprecipitates or cell extracts were eluted with SDS loading buffer (67.5 mM Tris-HCl, pH 6.8, 2.25% SDS, 10% glycerol, 5% β -mercaptoethanol, and bromophenol blue) and resolved by SDS-polyacrylamide gel electrophoresis. The proteins were transferred to polyvinylidene fluoride membranes (Immobilon P, Millipore) and incubated with the indicated antibodies. Immunoreactive proteins were visualized with anti-rabbit or anti-mouse IgG conjugated to horseradish peroxidase (GE Healthcare), followed by processing with an ECL detection system (GE Healthcare) and imaging using a ChmiDoc system (Bio-Rad, Richmond, CA). Intensities of bands were quantitated by using Image J software.
Nuclear protein extraction. Cells were washed with PBS and collected by centrifugation at 1,300 × g for 3 min. The cell pellet was lysed in hypotonic cytosol extraction buffer (10 mM HEPES, pH 7.9, 1.5 mM
